STAGE I PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE I PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE I PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE I PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study aims to stop prostate Cancer's return with Triple-Threat therapy
Disease control CompletedThis study tested whether adding a chemotherapy drug (docetaxel) to the standard post-surgery treatment of hormone therapy and radiation could better prevent prostate cancer from coming back. It involved over 600 men who had surgery for prostate cancer but were at high risk of re…
Matched conditions: STAGE I PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 02, 2026 00:26 UTC
-
Shorter radiation course tested to control prostate cancer with fewer side effects
Disease control CompletedThis study tested if a shorter, more intense radiation schedule (5 weeks) works as well as the standard longer schedule (7 weeks) for men who had surgery for prostate cancer. The main goal was to see if the shorter treatment caused fewer bowel and urinary side effects while still…
Matched conditions: STAGE I PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 01, 2026 14:49 UTC